<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01697098</url>
  </required_header>
  <id_info>
    <org_study_id>Dexa WHH</org_study_id>
    <nct_id>NCT01697098</nct_id>
  </id_info>
  <brief_title>Dexamethasone for Preterm Labour</brief_title>
  <acronym>PTL</acronym>
  <official_title>Dexamethasone Dosing Interval: 12 or 24 Hours Apart? A Randomized,Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators sought to determine whether the incidence of neonatal respiratory distress
      syndrome (RDS) in preterm fetuses is similar with 12- vs 24-hour dosing interval of
      dexamethasone.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The administration of glucocorticoids to accelerate fetal lung maturity in patients with
      preterm delivery plays an important role for obstetrics and neonatal care. Many studies have
      shown that maternal administration of glucocorticoids has a significant beneficial effect in
      decreasing the incidence of respiratory distress syndrome (RDS) in infants delivered at 28-34
      weeks of gestation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>respiratory distress syndrome (RDS)</measure>
    <time_frame>6 month</time_frame>
    <description>determine whether the incidence of neonatal respiratory distress syndrome (RDS) is similar with 12- vs 24-hour dosing interval of dexamethasone.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Perinatal mortality</measure>
    <time_frame>6 month</time_frame>
    <description>Determine whether the incidence of perinatal mortality is similar with 12- vs 24-hour dosing interval of dexamethasone.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Neonatal intensive care</measure>
    <time_frame>6 month</time_frame>
    <description>Determine whether the incidence of admission to Neonatal intensive care is similar with 12- vs 24-hour dosing interval of dexamethasone.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Prematurity</condition>
  <arm_group>
    <arm_group_label>12 hours Dexamethasone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Those patient will be given 12 hours dexamethasone after randomization</description>
  </arm_group>
  <arm_group>
    <arm_group_label>24 hours Dexamethasone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Those patient will be give 24 hours dexamethasone after randomization</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone 24 hours</intervention_name>
    <arm_group_label>24 hours Dexamethasone</arm_group_label>
    <other_name>glucocorticoids</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone 12</intervention_name>
    <arm_group_label>12 hours Dexamethasone</arm_group_label>
    <other_name>glucocorticoids</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patient with threatened or established preterm labor between 28 - 34 weeks
             attended to our emergency unit

        Exclusion Criteria:

          -  emergent obstetric conditions like:

               -  Antepartum hemorrhage in severe attack

               -  Antepartum eclampsia
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Women Health Hospital - Assiut university</name>
      <address>
        <city>Assiut</city>
        <zip>71111</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 23, 2012</study_first_submitted>
  <study_first_submitted_qc>September 28, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 2, 2012</study_first_posted>
  <last_update_submitted>September 28, 2012</last_update_submitted>
  <last_update_submitted_qc>September 28, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 2, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Mohammed Khairy Ali</investigator_full_name>
    <investigator_title>Women Health Hospital</investigator_title>
  </responsible_party>
  <keyword>Dexamethasone</keyword>
  <keyword>preterm labour</keyword>
  <keyword>respiratory distress</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Glucocorticoids</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

